Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden.
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Faith as a resource in patients with multiple sclerosis is associated with a positive interpretation of illness and experience of gratitude/awe.
Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis.
Involvement of MicroRNA in Microglia-Mediated Immune Response.
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
Anti-IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in CR-EAE ABH Mice.
Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study.
Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Fiber density index in the evaluation of the spinal cord in patients with multiple sclerosis.
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
Myelination Is Associated with Processing Speed in Early Childhood: Preliminary Insights.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Brain disorders where resources are scarce: The unfinished agenda.
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
The Use of Fourth-generation Optical Coherence Tomography in Multiple Sclerosis: A Review.
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS.
The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methods.
Emerging subspecialties in neurology: neuroimmunology.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Sunlight and Vitamin D: Necessary for Public Health.
Pages
« first
‹ previous
…
392
393
394
395
396
397
398
399
400
…
next ›
last »